StemCells, Inc. Receives FDA Approval to Initiate Clinical Trial of HuCNS-SC Cells in a Myelin Disease (Centre Daily Times)
StemCells, Inc. (NASDAQ:STEM) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to initiate a clinical trial of the Company s proprietary HuCNS-SC product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a fatal brain disorder that mainly affects young children. This Phase I trial is designed to evaluate the ...

FDA Panel Recommends Approval Of New, Less Costly Female Condom (Medical News Today)
An FDA advisory panel on Thursday voted 15-0 to recommend approval of the new, less costly version of the female condom developed by the Female Health Company, Reuters reports.

American Academy Of Dermatology Issues Statement On FDA Report To Congress About Labeling Information On Indoor ... (Medical News Today)
The American Academy of Dermatology (Academy) issued a statement in response to the Food and Drug Administration's Report to Congress about labeling information on the relationship between the use of indoor tanning devices and development of skin cancer or other skin damage. The FDA report was submitted pursuant to Section 230 of the Food and Drug Administration Amendments Act of 2007.